Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11008584 | Journal of Clinical Lipidology | 2018 | 7 Pages |
Abstract
In summary, the combination treatment with omega-3 fatty acids and acipimox could represent an alternative to other reported lipid-lowering therapies without severe adverse reactions.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
C. MD, A. MD, R. Mag, A. MD, R. MD, G. MD,